BCR and leukemia: In addition, the disruption of neddylation could not only induce apoptosis of the leukemic cells with BCR-ABL mutations [9], but also eradicate leukemia stem cells (LSCs) [10], strongly suggesting the advantageous outcomes of targeting this neddylation processes.